| 摘要 |
The invention concerns a composition for treating respiratory tract infections, characterised in that it combines menthol, eucalyptol and an amylolytic enzyme, said enzyme being preferably <i>Bacillus Amyolicfaciens</i> bacteria alpha-amylase. The inventive composition is particular suited for treating broncho-pulmonary and ORL sphere infections, particularly the oropharyngeal sphere.
|
